Article
The State Struggle: Paying for Excessively Priced Drugs
High-priced treatments continue to crush state budgets. With more drugs carrying 6-figure price tags, a problematic situation is playing out across the country.
High-priced treatments continue to crush state budgets. California, for example, has set aside $300 million to pay for new hepatitis C drugs. But unfortunately, that cost is just the tip of the iceberg, according to an article from The Fresno Bee.
With more drugs carrying 6-figure price tags, a problematic situation is playing out across the country. There’s the “impossible math” around how to afford hepatitis treatment in Rhode Island, as Rhode Island Public Radio reported. The state’s prison healthcare budget of $19 million must somehow pay for a hep C drug that will cost $150,000 for a round of treatment.
Read more at AHIP Coverage: http://bit.ly/1AUSgi9
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
